Search

Filter:
Did you mean
filed vaccine js js 1036bd7029d4c40e50f7ef48c5791a69 js

Search Results

Big Pharma backs EU antibiotic R&D plan, Pfizer prompts Karo cuts, Advent closes £146M fund

the resources to move its Helicobacter pylori vaccine into the clinic. Release Clal Biotech (TASE:CBI) unit ...

Novavax nabs FDA fast-track tag as search for H7N9 vaccine continues

the Maryland biotech a fast-track designation for its virus-like particle vaccine candidate. Novavax is developing the investigational vaccine under the company's 2011 contract with HHS' Biomedical ...

GI device player EndoChoice plans IPO for up to $150M

Fuse Full Spectrum Endoscopy System--Courtesy of EndoChoice Endoscopy system maker EndoChoice is the latest in a series of planned big-ticket med tech IPOs. The startup reportedly plans to file for an IPO on Nasdaq to raise $100 million to $150 million and value the company at as much as $600 million. ...

AstraZeneca wins FDA nod for SGLT2 combo diabetes med; Novo hiring in NH for new hemophilia factory;

> Novo Nordisk walks back some U.S. optimism for its next-gen insulin. Article Vaccines News > South African trial renews hopes in failed HIV vaccine combo. More > Dendreon's Provenge ...

FibroGen dials up a $155M IPO; AstraZeneca partners with University of Manchester;

Viehbacher in line for up to $7.8M cash payoff.  Report Vaccines News > South African trial renews hopes in failed HIV vaccine combo.  More > Dendreon's Provenge at the center of CMS insider trading ...

Little Cortendo gains $11M for late-stage Cushing's study, hatches U.S. IPO plans

Exactly when that filing could come and where, he adds, hasn't been determined yet.- here's ...

FDA encourages devices for the disabled; Volcano cuts 170 jobs;

More > Ex-Sanofi CEO Viehbacher in line for up to $7.8M cash payoff. Report Vaccines News > South African trial renews hopes in failed HIV vaccine combo. More > Dendreon's Provenge at the center ...

South African trial renews hopes in failed HIV vaccine combo

previously shown to impact the protective effect of the vaccines. Known as RV144, after the original Thai ...

Dendreon's Provenge at the center of CMS insider trading probe

The SEC is investigating whether officials at the Center for Medicare and Medicaid Services (CMS) tipped off a policy research group about the agency's review of Dendreon's ($DNDN) cancer vaccine, Provenge, The Wall Street Journal reports. Dendreon's stock plunged 26% between June 1, 2010, ...

Bristol-Myers' nivolumab impresses once again--this time in crucial lung cancer study

($MRK) to the market with a PD-1 drug that can extend the lives of patients. It recently filed ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »